For the Inventor, By the Inventor

Enter assignee name

Anderlecht, Belgium

Ogeda Sa

Calculating rank

USPTO Granted Patents = 23

CIPO Patents = 1

EPO Patents = 8

Forward Citations = 19

Loading Chart...

Loading Chart...

11 inventors (with patents filed for the assignee):

Hamid R Hoveyda (23 out of 51 patents)

Graeme Lovat Fraser (18 out of 38 patents)

Guillaume Dutheuil (16 out of 23 patents)

4. Marie-Odile Roy (6 out of 10 patents)

5. Didier Schils (3 out of 7 patents)

6. Ludivine Zoute (3 out of 7 patents)

7. Julien Parcq (3 out of 9 patents)

8. Frederic Batt (3 out of 4 patents)

9. Mohamed El Bousmaqui (2 out of 3 patents)

10. Jerome Bernard (1 out of 1 patent)

11. Mohamed E Bousmaqui (1 out of 1 patent)

12. Marie-Odile Roy (0 patent)

23 patents: Sort by Forward Citations

1. 12458641 - NK-3 receptor antagonists for therapeutic or cosmetic treatment of excess body fat (2025-11-04),

2. 12162849 - Synthesis of 3-methyl-1,2,4-thiadiazole-5-carbohydrazide or of the methyl-deuterated form thereof (2024-12-10),

3. 11731974 - N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists (2023-08-22),

4. 11478472 - NK-3 receptor antagonists for therapeutic treatment of leptin-related disease (2022-10-25),

5. 11078203 - Deuterated fezolinetant (2021-08-03),

6. 10941151 - Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof (2021-03-09),

7. 10836768 - N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists (2020-11-17),

8. 10787458 - Chiral synthesis of N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-A]pyrazines (2020-09-29),

9. 10683295 - Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-A]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof (2020-06-16),

10. 10624890 - NK-3 receptor antagonists for therapeutic or cosmetic treatment of excess body fat (2020-04-21),

11. 10544150 - NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders (2020-01-28),

12. 10214533 - N-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders (2019-02-26),

13. 10183948 - N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists (2019-01-22),

14. 10065961 - Chiral N-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof (2018-09-04),

15. 10065960 - NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders (2018-09-04),

Company Overview

Ogeda Sa is a biopharmaceutical company based in Anderlecht, Belgium, focused on the development of innovative therapies for unmet medical needs. The organization specializes in research and development within the fields of endocrinology and reproductive health, aiming to address conditions that significantly impact patients' quality of life. Ogeda's commitment to advancing healthcare solutions is reflected in its dedication to scientific excellence and collaboration within the global medical community.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

23 Patents

#1 in Anderlecht

#146 in Belgium

#27,736 in the World

Anderlecht, Belgium

Ogeda Sa

Forward Citations = 19

11 inventors:

Hamid R Hoveyda (23 out of 51 patents)

Graeme Lovat Fraser (18 out of 38 patents)

Guillaume Dutheuil (16 out of 23 patents)

4. Marie-Odile Roy (6 out of 10 patents)

5. Didier Schils (3 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ogeda Sa. Retrieved from https://idiyas.com/company/ogeda-sa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…